A widely criticized bill that offers protection to executives and directors of Pennsylvania’s Sovereign Bank against a shareholder challenge was signed into law by the governor last week amid opposition from shareholders and charges that the state legislature bent their own rules to ensure the bill’s swift passage.
An international battle over valuable patents for stem cell research is brewing between one-time collaborators in South Korea and the United States who have filed competing patent applications despite the public collapse of the research’s reliability.
A bitter breakup with his former mentor and a pesky federal investigation into alleged rewards for lead plaintiffs haven’t stopped William Lerach from cementing his position as the dean of the securities litigation plaintiffs bar.
In a secretive overnight vote, Pennsylvania legislators have rushed through a bill that makes a deep dent in shareholders' campaign to block Sovereign Bankcorp.'s three-way deal with a Spanish bank and a New York thrift.
In the latest chapter in a drawn-out battle fought in courtrooms on two continents, Matsushita Electric Industrial Co. has sued Samsung Electronics Co. Ltd. in a Texas federal court, accusing the South Korean rival of infringing patents for memory chip technology.
A fusillade of filings, accusations, lawsuits and counterstrikes between Sovereign Bancorp. and its largest institutional investor has led a federal judge to order the combatants to curb their public attacks on each other and stop filing papers, while also killing a motion by the Philadelphia company to dismiss two lawsuits by its shareholder.
The California Public Employees' Retirement System (Calpers), the nation’s largest public pension fun, has joined the tug-of-war between Sovereign Bancorp Inc. and a growing group of institutional investors over a complicated deal that involves selling 20% of the company’s shares to a Spanish bank.
The securities litigation practice at Gibson Dunn & Crutcher will soon have an even better understanding of the inner workings of securities regulators, with former head of the National Association of Securities Dealers enforcement division Barry Goldstein as the firm’s latest hire.
Sovereign Bancorp Inc. has asked the Securities and Exchange Commission to investigate a claim by its largest shareholder that the bank failed to disclose business ties with the author of an editorial that backed its controversial takeover bid.
In a fresh sign that intellectual property matters will weigh heavily at the U.S. Supreme Court this year, justices have asked the Bush administration's solicitor general for advice while considering the appeal of U.K. drug maker GlaxoSmithKline Plc over its antidepressant Paxil.
A move by Sovereign Bancorp Inc. to delay its annual meeting by several months has enraged its largest shareholder, which claims the company’s management is trying to push through a complicated merger deal without the support of investors.
Two companies are locked in a bitter dispute over who owns the rights to technology that allows mobile users to safely access their company’s network from an off-site location and bounce from network to network without interruption.
Finish mobile phone maker Nokia Corp. has lost its final bid to avoid paying a $252 million award to wireless technology firm InterDigital Communications Corp. to settle drawn-out arbitration between the two rivals.
Pharmaceutical company Cephalon Inc. dropped its lawsuit Thursday against generic drug maker Ranbaxy Laboratories Ltd. over the sleeping disorder treatment Provigil.
In a victory for Johnson & Johnson, the U.S. Court of Appeals for the Federal Circuit affirmed a lower court’s ruling preventing drug maker Mylan Laboratories Inc. from duplicating its lucrative anti-infective drug Levaquin.
After a six-year feud over a potential blockbuster drug, a small family-owned pharmaceutical company has been awarded $48 million from a biotechnology firm accused of illegally licensing its patents.
The largest shareholder of Sovereign Bancorp Inc. is petitioning regulators to halt a $2.4 billion deal between Sovereign and a major Spanish bank, claiming the New York Stock Exchange will be in violation of its own rules if it prevents shareholders from voting on the deal.
Extending the drawn-out legal row over generic Wellbutrin, a subsidiary of Andrx Pharmaceuticals LLC has sued British rival GlaxoSmithKline PLC, alleging the company’s current formula for the antidepressant infringes Andrx’s patent.
Sovereign Bancorp Inc.'s largest shareholder, Relational Investors LLC, has filed a lawsuit to stop a $3.6 billion deal between the bank, Spain's Banco Santander Central Hispano SA and Independence Community Bank Corp.
Samsung Electronics Co. and Hynix Semiconductor Inc., both competitors in the semiconductor industry, have been sued in federal court over two chip technology patents.